Cases | Controls | ||||
---|---|---|---|---|---|
(n = 183) | (n = 217) | ||||
Antibody | Mean | SD | Mean | SD | Difference |
HPyV | |||||
MCVb VP1c | 8.4 | 2.5 | 8.4 | 2.5 | 0 |
MCVb ST-Agd | 1.1 | 1.8 | 1.1 | 2 | 0 |
KIVe VP1 c | 9 | 1.9 | 8.9 | 1.5 | 0.1 |
KIVe ST-Agd | 1.9 | 1.9 | 1.9 | 1.9 | 0 |
WUVf VP1 c | 9.2 | 1 | 9.1 | .8 | 0.1 |
WUVf ST-Agd | 1.7 | 1.8 | 1.6 | 1.7 | 0.1 |
HPVg 16 | |||||
E6 | .4 | 1.2 | .2 | 1 | 0.2 |
E7 | 1.7 | 2.6 | 1.4 | 2.3 | 0.3 |
L1 | 1.3 | 2.1 | 1.1 | 1.9 | 0.2 |
HPVg 18 | |||||
E6 | 1.6 | 2 | 1.5 | 1.9 | 0.1 |
E7 | .6 | 1.6 | .5 | 1.4 | 0.1 |
L1 | 2.1 | 2 | 2.1 | 1.9 | 0 |
Other high-risk HPVg | |||||
31 L1 | 2.6 | 2.3 | 2.6 | 2.5 | 0 |
33 L1 | 1.8 | 2 | 1.7 | 1.9 | 0.1 |
52 L1 | 5 | 2 | 5 | 1.9 | 0 |
58 L1 | 3.5 | 2.4 | 3.4 | 2.3 | 0.1 |
Low-risk HPVg | |||||
6 L1 | 5.1 | 2.7 | 4.9 | 2.6 | 0.2 |
11 L1 | 4 | 2.4 | 3.7 | 2.4 | 0.3 |